CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 186 filers reported holding CHEMOCENTRYX INC in Q2 2022. The put-call ratio across all filers is 0.26 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $2,279,000 | -1.2% | 92 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $2,306,000 | -31.2% | 92 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $3,350,000 | -98.9% | 92 | -99.5% | 0.00% | -98.7% |
| Q3 2021 | $314,731,000 | +2.0% | 18,406 | -2.8% | 0.08% | +8.6% |
| Q2 2021 | $308,591,000 | -71.3% | 18,944 | -9.8% | 0.07% | -77.3% |
| Q1 2021 | $1,076,249,000 | -13.2% | 21,005 | +5.0% | 0.31% | -15.6% |
| Q4 2020 | $1,239,210,000 | +1160.6% | 20,014 | +1015.6% | 0.36% | +1203.6% |
| Q3 2020 | $98,306,000 | +6.0% | 1,794 | +11.3% | 0.03% | +12.0% |
| Q2 2020 | $92,748,000 | +8.4% | 1,612 | -24.3% | 0.02% | +4.2% |
| Q1 2020 | $85,539,000 | – | 2,129 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 545,532 | $13,518,000 | 5.54% |
| Integral Health Asset Management, LLC | 574,029 | $14,224,000 | 2.93% |
| HealthCor Management, L.P. | 1,097,370 | $27,193,000 | 2.73% |
| Logos Global Management LP | 600,000 | $14,868,000 | 2.73% |
| Cormorant Asset Management, LP | 1,425,000 | $35,312,000 | 2.67% |
| Altium Capital Management LP | 160,000 | $3,965,000 | 1.59% |
| Cahill Wealth Management, LLC | 68,358 | $1,693,000 | 1.43% |
| Hood River Capital Management LLC | 1,336,776 | $33,125,000 | 1.32% |
| Sofinnova Investments, Inc. | 636,659 | $15,776,000 | 1.31% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 3,000 | $121,100,000 | 1.26% |